US is the biggest market for Indian pharmaceutical companies and Biden's presidency is expected to bring with it some favourbable changes that could have a long-ranging impact.
Modi govt is looking at total sales of Rs 500 cr in 2020-21 under Pradhan Mantri Bhartiya Janaushadhi Pariyojana, approximately 15% higher than last year’s Rs 433 cr.
A focus on repurposing generic drugs would give researchers more shots on goal in the game of drug discovery, improving the odds that a winning treatment will emerge.
Modi govt’s efforts seek to address criticism lobbed at India for failing to discover even a single drug molecule despite being the largest producer of generic medicines in the world.
While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.
Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.
COMMENTS